Mrs Tammy M Ranney, PT | |
4776 Overbury Pl, Sarasota, FL 34241-9227 | |
(941) 447-4171 | |
Not Available |
Full Name | Mrs Tammy M Ranney |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 4776 Overbury Pl, Sarasota, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013945021 | NPI | - | NPPES |
Y097U | Other | FL | BLUE CROSS & BLUE SHIELD |
P00685897 | Other | FL | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT21424 (Florida) | Primary |
Provider Name | West Coast Therapy Specialist Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1578810776 PECOS PAC ID: 0648549618 Enrollment ID: O20170706002356 |
News Archive
Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).
The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.
Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.
› Verified 4 days ago
Provider Name | Neighborhood Pt, Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1457061699 PECOS PAC ID: 1456724798 Enrollment ID: O20230307001742 |
News Archive
Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).
The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.
Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Tammy M Ranney, PT 4776 Overbury Pl, Sarasota, FL 34241-9227 Ph: (941) 447-4171 | Mrs Tammy M Ranney, PT 4776 Overbury Pl, Sarasota, FL 34241-9227 Ph: (941) 447-4171 |
News Archive
Cells possess a variety of ways of dealing with mutations that can cause them to grow uncontrollably and eventually form a tumor. The tumor suppressor gene p53 plays a critical role in these cancer prevention processes, largely by triggering a form a cell death known as apoptosis.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).
The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a study by Henry Ford Hospital. Patients receiving white cadaveric donor grafts had significantly more aggressive recurrent hepatitis C than those receiving grafts from African-American donors regardless of recipient race, says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.
Tris Pharma, Inc. is pleased to announce that the U.S. Food and Drug Administration approved the first-ever extended-release (ER) chewable tablet, capping off a highly productive year with three Tris-developed NDAs approved in a calendar year.
› Verified 4 days ago
The Weston Group Of Florida Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5311 Proctor Rd, Sarasota, FL 34233 Phone: 941-538-0950 | |
Active Life Therapy Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4000 Sawyer Rd, Sarasota, FL 34233 Phone: 941-586-7110 Fax: 941-921-4820 | |
Kevin Steele, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2055 Wood St Ste 110, Sarasota, FL 34237 Phone: 941-330-1677 Fax: 941-330-1688 | |
Joyce Hegeman, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1959 N Honore Ave, Sarasota, FL 34235 Phone: 941-462-3980 Fax: 941-371-6827 | |
Michael Ehlers, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2750 Bahia Vista St, Sarasota, FL 34239 Phone: 941-951-2663 | |
Kyle Backofen, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6150 N Lockwood Ridge Rd, Sarasota, FL 34243 Phone: 941-960-4741 | |
Melissa Guet, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 University Pkwy Ste 103, Sarasota, FL 34243 Phone: 941-444-5970 |